Symposia: Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Biological therapies, Lymphoid Leukemias, Acute Myeloid Malignancies, ALL, AML, Fundamental Science, clinical trials, adult, Translational Research, Clinical Research, GVHD, pediatric, Diseases, Immune Disorders, immune mechanism, Therapies, immunology, Immunotherapy, real-world evidence, Adverse Events, Lymphoid Malignancies, Biological Processes, Myeloid Malignancies, Study Population, Human, pathogenesis
Type: Oral
Hematology Disease Topics & Pathways:
Research, Biological therapies, Lymphoid Leukemias, Acute Myeloid Malignancies, ALL, AML, Fundamental Science, clinical trials, adult, Translational Research, Clinical Research, GVHD, pediatric, Diseases, Immune Disorders, immune mechanism, Therapies, immunology, Immunotherapy, real-world evidence, Adverse Events, Lymphoid Malignancies, Biological Processes, Myeloid Malignancies, Study Population, Human, pathogenesis
Saturday, December 10, 2022: 9:30 AM-11:00 AM
252-254
(Ernest N. Morial Convention Center)
Moderators:
Susan DeWolf, MD, Memorial Sloan Kettering Cancer Center
and
Kate A Markey, MBBS, PhD, FRACP, MPH, ARRAY(0xe597a00)
Disclosures:
Markey: Incyte: Consultancy; Postbiotics Plus: Current equity holder in private company, Membership on an entity's Board of Directors or advisory committees.
This session will highlight interesting new data from groups exploring T cell recovery after transplantation and include presentations of clinical data which may offer new mechanistic insights.
9:30 AM
9:45 AM
10:00 AM
10:15 AM
10:30 AM
10:45 AM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH